Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Breakthrough in nanoparticle technology could expand access to biologic medicines

In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) have engineered polymer-based nanoparticles that form with a simple te

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) have engineered polymer-based nanoparticles that form with a simple temperature shift-no harsh chemicals, no specialized equipment, and no processing needed.

The new nanoparticles, described in Nature Biomedical Engineering, self-assemble at room-temperature in water and, because of these gentle conditions, can deliver proteins, which are unstable in many existing nanoparticle formulations.

What excites me about this platform is its simplicity and versatility. By simply warming a sample from fridge temperature to room temperature, we can reliably make nanoparticles that are ready to deliver a wide variety of biological drugs." Stuart Rowan, co-senior author, the Barry L. MacLean Professor for Molecular Engineering Innovation and Enterprise at UChicago Pritzker Molecular Engineering and staff scientist Argonne National Laboratory

From problem to platform

Nanoparticles are key to protecting delicate drugs like RNA and proteins from being degraded in the body before they reach the right cells. Lipid nanoparticles (LNPs), made of fatty molecules, enabled the COVID-19 mRNA vaccines, for instance. But LNPs rely on alcohol-based solvents and sensitive manufacturing steps-making them poorly suited for protein delivery and hard to scale.

"We wanted to make a delivery system that could work for both RNA and protein therapies-because right now, most platforms are specialized for just one," said first author Samir Hossainy, a UChicago PME graduate student. "We also wanted to make it scalable, without needing toxic solvents or complicated microfluidics."

Hossainy hypothesized that polymer-based nanoparticles could offer a more robust, customizable alternative. He outlined the required characteristics; the immune system will only respond to particles with certain sizes, shapes, and charges. Then, he used chemical tools to begin designing new nanoparticles from scratch.

After trying, and fine-tuning, more than a dozen different materials, he found one that worked. In cold water, the polymer-and any desired protein-remained dissolved. But when heated to room temperature, the polymer self-assembled into uniformly sized nanoparticles (or "polymersomes") surrounding the protein molecules.

"Our particle size and morphology is dictated only by the chemistry of the polymers that I designed from the bottom up," explained Hossainy. "We don't have to worry about different particle sizes forming, which is a challenge with a lot of today's nanoparticles."

Carrying versatile cargo

To test the new polymersomes, Hossainy worked with colleagues in Rowan's lab as well as with former UChicago PME Prof. Jeffrey Hubbell, now at New York University. First, they showed that the particles can encapsulate more than 75% of protein and nearly 100% of short interfering RNA (siRNA) cargo-far higher than most current systems-and they can be freeze-dried and stored without refrigeration until needed.

In the context of vaccination, Hossainy and his collaborators found that the polymersomes could effectively carry a protein and, when injected into mice, lead the animals' immune systems to generate long-lasting antibodies against that protein. Another experiment showed that the nanoparticles could also carry proteins designed to prevent an immune response in the context of allergic asthma. And a third showed that injecting polymersomes into tumors could block cancer-related genes and suppress tumor growth in mice.

"The exciting thing is that we didn't need to tailor a different system for each use case," said Hossainy. "This one formulation worked for everything we tried-proteins, RNA, immune activation, immune suppression, and direct tumor targeting."

A scalable solution for worldwide vaccines

One of the biggest advantages of the new polymersomes over current LNPs is the potential for low-tech, decentralized production. Hossainy says he imagines being able to ship freeze-dried formulations of the nanoparticles to anywhere in the world. When they need to be used, they can be mixed in cold water, warmed up, and will be ready to deliver to patients.

"Being able to store these dry drastically improves the stability of the RNA or protein," said Hossainy.

The group is continuing to work on fine-turning the particles to carry more types of cargo, including messenger RNA like that used in the COVID-19 vaccines (generally much larger than the siRNA used in the current trial). They also plan to collaborate on pre-clinical trials to apply the polymersomes to real-world vaccine or drug delivery challenges.

Hossainy, S., et al. (2025). Thermoreversibly assembled polymersomes for highly efficient loading, processing and delivery of protein and siRNA biologics. Nature Biomedical Engineering. doi.org/10.1038/s41551-025-01469-7.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What does an AI-assisted drug safety workflow realistically look like today?

Toxicology is a very diverse field, spanning chemistry, biology, and clinical science. Data varies enormously in accessibility, quantity, quality, terminology, and format. That makes it a complex domain for AI, but also one where AI can be very useful when applied carefully. A realistic AI-assisted safety pipeline today is not about replacing the expert toxicologist. It is about augmentation. AI agents and Large Language Models (LLMs) can autonomously search for data, collate information, generate summaries, and produce plots. This allows safety scientists to bring their expertise to bear more efficiently, while AI helps uncover and organize the evidence. We should also remember task-specific models. DeepDILI, for example, combined classical and deep learning approaches to predict drug-induced liver injury (DILI), a major cause of post-marketing drug withdrawals. Models like this can have a real impact when focused on specific safety pain points.

Source: www.news-medical.net ↗
02How does vitamin D strengthen the immune system?

More specifically, the study showed that the female patient produced very few cathelicidins, which is a natural toxin found in the immune cells of the lungs needed to fight tuberculosis. In most people infected by tuberculosis, tuberculosis bacteria attack the immune cells of the lungs. The immune cells fight the bacteria by eating them. But the tuberculosis bacterium has developed various evasive mechanisms that reduce the immune cells’ ability to digest and thus to kill the Mtb. “You could say that the tuberculosis bacterium has developed a way to lull the immune cells to sleep. This enables the disease the hide inside the immune cells, making it invisible to other parts of the immune system,” Martin Kongsbak-Wismann explains. This is where vitamin D enters the picture. Because vitamin D is able to counteract the soporific effect of the tuberculosis bacteria by making the immune cells produce more of the cathelicidin toxin. “Cathelicidin is like a microscopic needle that is able to pierce the tuberculosis bacteria. And when it does, it weakens the bacteria’s soporific effect on the immune cells. This restores the immune cells’ ability to kill tuberculosis bacteria,” says Martin Kongsbak-Wismann and adds: “We were amazed by the effect of vitamin D. In immune cells from healthy control subjects, vitamin D improved the cells’ ability to fight Mtb, whereas in the female patient’s immune cells we saw no response to vitamin D. This shows that vitamin D is key to the immune system’s ability to fight Mtb and prevent tuberculosis.” Al-Jaberi, F.A.H., et al. (2022) Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report. Frontiers in Immunology. doi.org/10.3389/fimmu.2022.1038960.

Source: www.news-medical.net ↗
03How important is it to pick the right target in drug discovery? Could artificial intelligence (AI) be used to aid this process?

Picking the right target is absolutely fundamental. I mentioned that over half of failures of new medicines in development are due to us picking the wrong target. Even if we just doubled our success rate at picking the right target, it would have a huge impact on the development of new medicines for people. One of the reasons, and why I think artificial intelligence could be really important in helping us do that, is that, quite often, there may be some data buried in the literature that tells us a target is really good. Equally valuable is the fact that there may be something buried in the literature that tells you a target is not good. It's much harder to publish negative data than positive data. That target invalidation can be just as valuable as a target validation. It's really about being able to tap into all that knowledge and look up all the facts. That would mean that our systems and other people's AI systems can really be much more effective at picking the right target.

Source: www.news-medical.net ↗
04What is carb cycling?

Carb cycling is an attempt to fine-tune your carbohydrate consumption to alter many aspects of your metabolism. Your plan will include the same protein intake each day but vary carbohydrates according to your activity. Your carb cycling plan may have three low or zero carb days, two moderate carb days, and two high carb days. Meeting your calorie requirements will require including more fats on low-carb days. Carb cycling needs much more planning than a usual calorie-controlled diet. One way is to match your carb cycling to your physical activity. If you go to the gym thrice a week, you could have carbs on those days. The carbs provide energy for your workout, prevent fatigue, and avoid the muscle loss sometimes seen with dieting. The days when you eat little to no carbs force your body to generate energy from other sources, like proteins and fats. But the days when you eat more carbohydrates might reverse this change. You must only eat a high-carb diet on the days you have a heavy workout, which uses up the calories.

Source: www.medicinenet.com ↗
05From Spirulina to Seaweed: How are different types of algae integral to human diets?

Algae are photosynthetic aquatic creatures that grow through the consumption of nutrients, light, and carbon dioxide. They are a diverse group of creatures that include tiny single-celled algae and enormous kelp, as well as seaweed 1. Numerous prokaryotic and eukaryotic algae species are desirable food sources for humans due to their inherent qualities 2,3. Human intake of macroalgae such as seaweed and microalgae like phytoplankton dates back many years. Multicellular macroscopic aquatic plants, or macroalgae, are classified into three taxa: Phaeophyceae, or brown algae, Rhodophyta or red algae, and Chlorophyta or green algae. Microalgae, the unicellular counterpart of macroalgae, are categorized in a broader framework that includes prokaryotic cyanobacteria (blue-green algae), Euglenophyta, and Chlorophyta, which are genetically distinct from one another. The ancient populations of Chad and the Aztec culture were already familiar with the cyanobacteria spirulina, which is currently advertised as a superfood in the West 4. In Burma, Vietnam, and India, other cyanobacteria/microalgae, like Spirogyra and Oedogonium, were eaten as food or as a supplement 4. Seaweed is a staple of daily meals in many Asian and Pacific civilizations, including Korea, Japan, and Indonesia, as well as Hawaii and New Zealand 5.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →